Age

18–90

Sex

ALL

Healthy volunteers

Accepted

Patients with glaucoma who developed corneal epitheliopathy secondary to antihypertensive drops;
Epitheliopathy refractory to conventional therapies (Artificial Tears, ointment, topical cyclosporine or punctal plug, etc.);
National Eye Institute score of 3 or more for both eyes;
Adults aged 18 to 90 years inclusively.

Corneal epitheliopathy of other origin (ie. mechanical, neurotrophic, toxic, post-infectious, limbal stem cell deficiency);
Glaucoma surgery within the last six (6) months;
Previous corneal surgery;
Active autoimmune disease;
Frequent contact lense wear;
Pregnant or actively breast-feeding;
Known systemic infection with HIV, hepatitis B and C or syphilis;
Known severe anemia (Hb \< 100 g/L);
Inability to give informed consent

Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.